Both in Biotechnology
Estrella Immunopharma vs Dyadic International
Over the past year ESLA returned −80.6% and DYAI returned −65.1%; their daily moves had a correlation of 0.02.
ESLA −80.6% DYAI −65.1%Growth of $1, one year, split-adjusted
| Metric | ESLA | DYAI |
|---|---|---|
| Price | $0.4435 | $0.3667 |
| Market cap | $19.3M | $14.7M |
| Today | +6.10% | +1.86% |
| 1 month | +3.4% | −19.1% |
| 6 months | −65.9% | −51.8% |
| Year to date | −71.6% | −61.0% |
| 1 year | −85.5% | −66.0% |
| Revenue growth (YoY) | — | −0.6% |
| Gross margin | — | −2.4% |
| Net margin | — | −221.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.9× |
| Net cash | $146.7K | -$1.9M |
| Dividend yield | — | — |
| Volatility (60d) | 201.6% | 76.8% |
| Short % of float | 4.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).